Envestnet Asset Management’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-30,370
Closed -$151K 4077
2022
Q2
$151K Buy
+30,370
New +$159K ﹤0.01% 3691
2021
Q3
Sell
-12,134
Closed -$544K 3787
2021
Q2
$544K Buy
12,134
+3,466
+40% +$161K ﹤0.01% 2924
2021
Q1
$435K Buy
+8,668
New +$591K ﹤0.01% 2926

Other funds holding CELL

Envestnet Asset Management's CELL Position: Q3 2022 in Review

Envestnet Asset Management sold out of PhenomeX Inc. Common Stock (CELL) in Q3 2022, closing a stake of 30,370 shares — an estimated $151K sold.

Envestnet Asset Management first reported a position in CELL in Q1 2021 and held it in 3 quarters. The position peaked at $544K in Q2 2021. 113 funds tracked by Wall St. Rank hold CELL as of Q3 2022.

  • Envestnet Asset Management reported no remaining PhenomeX Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Envestnet Asset Management sold 30,370 PhenomeX Inc. Common Stock shares in Q3 2022, an estimated $151K.
  • Envestnet Asset Management first reported a position in PhenomeX Inc. Common Stock in Q1 2021 and held it in 3 quarters.
  • Envestnet Asset Management's PhenomeX Inc. Common Stock position peaked at $544K in Q2 2021.
  • 113 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q3 2022.

Based on Envestnet Asset Management's 13F filing for Q3 2022, filed 10 Nov 2022.